A Response to Article Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year after Standard Treatment [Letter]

Detalles Bibliográficos
Autor principal: Panjaitan, Novaria Sari Dewi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700466/
https://www.ncbi.nlm.nih.gov/pubmed/36444283
http://dx.doi.org/10.2147/OTT.S396245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700466/
https://www.ncbi.nlm.nih.gov/pubmed/36444283
http://dx.doi.org/10.2147/OTT.S396245

Ejemplares similares